(Q50517496)

14 March 2018

title

Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1. (English)

1 reference

14 March 2018

G protein-coupled receptor

main subject

1 reference

2

1 reference

14 March 2018

author name string

Ryan L Brunsing

series ordinal

1

1 reference

14 March 2018

publication date

2 July 2011

1 reference

14 March 2018

published in

Immunology

1 reference

14 March 2018

volume

134

1 reference

14 March 2018

issue

1

1 reference

14 March 2018

page(s)

93-106

1 reference

14 March 2018

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

T helper 17 cells: discovery, function, and physiological trigger

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

How regulatory T cells work

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Digestive histopathological presentation of IPEX syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Interleukin-10-deficient mice develop chronic enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

The regulation of IL-10 production by immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Tr1 cells: from discovery to their clinical application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Strategies for use of IL-10 or its antagonists in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

The functional plasticity of T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Developmental plasticity of Th17 and Treg cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Hybrid Treg cells: steel frames and plastic exteriors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

ATP drives lamina propria T(H)17 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Cutting edge: Alternative signaling of Th17 cell development by sphingosine 1-phosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

In vivo effects of a GPR30 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

B cell depletion reduces the development of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Interleukin-17: friend or foe in atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

A protective function for interleukin 17A in T cell-mediated intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Oestrogen-mediated protection of experimental autoimmune encephalomyelitis in the absence of Foxp3+ regulatory T cells implicates compensatory pathways including regulatory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Virtual and biomolecular screening converge on a selective agonist for GPR30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Estrogen signaling through the transmembrane G protein-coupled receptor GPR30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

GPR30 contributes to estrogen-induced thymic atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

IL-17-producing human peripheral regulatory T cells retain suppressive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

IL-21 mediates suppressive effects via its induction of IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2011.03471.X

Cellular and molecular characterization of the scurfy mouse mutant

21 January 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173698

Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10

2 November 2018

1 reference

12 December 2020

IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses

1 reference

12 December 2020

Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Regulatory T cells dynamically control the primary immune response to foreign antigen

1 reference

12 December 2020

Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1)

1 reference

12 December 2020

Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production

1 reference

12 December 2020

Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells

1 reference

12 December 2020

10.1111/J.1365-2567.2011.03471.X

Identifiers

DOI

1 reference

14 March 2018

0 references

1 reference

14 March 2018